Segment disclosures

Company overview

제이시스메디칼

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 13 retained observations 9 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-3150755217041 KRW20210317Open filing evidence
2020-07-01 – 2020-09-3015185462227 KRW20201130Open filing evidence
2020-01-01 – 2020-09-3035483106145 KRW20201130Open filing evidence
2020-04-01 – 2020-06-308637306406 KRW20201215Open filing evidence
2020-01-01 – 2020-06-3020297643918 KRW20201215Open filing evidence
2020-01-01 – 2020-03-3111660337512 KRW20201215Open filing evidence
2019-01-01 – 2019-12-3136800567302 KRW20210317Open filing evidence
2019-07-01 – 2019-09-3011451029105 KRW20201130Open filing evidence
2019-01-01 – 2019-09-3026654588257 KRW20201130Open filing evidence
2019-04-01 – 2019-06-308263990208 KRW20201215Open filing evidence
2019-01-01 – 2019-06-3015203559152 KRW20201215Open filing evidence
2019-01-01 – 2019-03-316939568944 KRW20201215Open filing evidence
2018-01-01 – 2018-12-3128541149159 KRW20210317Open filing evidence